Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482948 · ClinicalTrials.gov registry record · NA
MEDIHONEY® Gel Versus Collagenase for Wound Debridement
A NA study, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02482948 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 10 participants.
The verdict
NCT02482948, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue.
Interventions
- DRUG Collagenase
- DEVICE Active Leptospermum Honey (Medihoney)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482948
The ClinicalTrials.gov registry entry for NCT02482948 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collagenase is the first listed.
NCT02482948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02482948 about?
NCT02482948 is a clinical study titled "MEDIHONEY® Gel Versus Collagenase for Wound Debridement". The purpose of this study is to compare how well two products, Active Leptospermum Honey (ALH) (MEDIHONEY® Gel) and Collagenase (Santyl®), in removing the nonviable (non living) tissue.
What is the current status of trial NCT02482948?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-06. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02482948?
The interventions under investigation include: Collagenase (DRUG), Active Leptospermum Honey (Medihoney) (DEVICE).
Who is sponsoring clinical trial NCT02482948?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.